Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
About this item
Full title
Author / Creator
Stepan, J. J , Burr, D. B , Li, J , Ma, Y. L , Petto, H , Sipos, A , Dobnig, H , Fahrleitner-Pammer, A , Michalská, D and Pavo, I
Publisher
London: London : Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
London: London : Springer-Verlag
Subjects
More information
Scope and Contents
Contents
Summary The level of increased bone formation after 24 months of treatment with teriparatide (rhPTH (1-34), TPTD) is similar in patients who were either treatment-naïve (TN) or had lower bone turnover initially due to previous alendronate (ALN) therapy. Introduction Bone anabolic effects of TPTD in postmenopausal women with osteoporosis may be blun...
Alternative Titles
Full title
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_954611516
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_954611516
Other Identifiers
ISSN
0937-941X
E-ISSN
1433-2965
DOI
10.1007/s00198-009-1168-7
